Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May;149(4):438-451.
doi: 10.1111/jnc.14615. Epub 2018 Nov 26.

In vivo molecular imaging of neuroinflammation in Alzheimer's disease

Aisling Chaney  1   2 , Steve R Williams  1 , Herve Boutin  2   3
Affiliations
Review

In vivo molecular imaging of neuroinflammation in Alzheimer's disease

Aisling Chaney et al. J Neurochem. 2019 May.

Abstract

It has become increasingly evident that neuroinflammation plays a critical role in the pathophysiology of Alzheimer's disease (AD) and other neurodegenerative disorders. Increased glial cell activation is consistently reported in both rodent models of AD and in AD patients. Moreover, recent genome wide association studies have revealed multiple genes associated with inflammation and immunity are significantly associated with an increased risk of AD development (e.g. TREM2). Non-invasive in vivo detection and tracking of neuroinflammation is necessary to enhance our understanding of the contribution of neuroinflammation to the initiation and progression of AD. Importantly, accurate methods of quantifying neuroinflammation may aid early diagnosis and serve as an output for therapeutic monitoring and disease management. This review details current in vivo imaging biomarkers of neuroinflammation being explored and summarizes both pre-clinical and clinical results from molecular imaging studies investigating the role of neuroinflammation in AD, with a focus on positron emission tomography and magnetic resonance spectroscopy (MRS).

Keywords: TSPO; Alzheimer's disease; magnetic resonance spectroscopy; neuroimaging; neuroinflammation; positron emission tomography.

PubMed Disclaimer

References

    1. Agdeppa E. D., Kepe V., Liu J. et al (2001) Binding characteristics of radiofluorinated 6‐dialkylamino‐2‐naphthylethylidene derivatives as positron emission tomography imaging probes for beta‐amyloid plaques in Alzheimer's disease. J. Neurosci. 21, RC189. - PMC - PubMed
    1. Ahmad R., Koole M., Evens N., Serdons K., Verbruggen A., Bormans G. and Van Laere K. (2013) Whole‐body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]‐NE40 in healthy subjects. Mol. Imaging Biol. 15, 384–390. - PubMed
    1. Banati R. B. (2002) Visualising microglial activation in vivo. Glia 40, 206–217. - PubMed
    1. Bates T. E., Strangward M., Keelan J., Davey G. P., Munro P. M. and Clark J. B. (1996) Inhibition of N‐acetylaspartate production: implications for 1H MRS studies in vivo. NeuroReport 7, 1397–1400. - PubMed
    1. Benavides J., Cornu P., Dennis T., Dubois A., Hauw J. J., MacKenzie E. T., Sazdovitch V. and Scatton B. (1988) Imaging of human brain lesions with an omega 3 site radioligand. Ann. Neurol. 24, 708–712. - PubMed

Publication types